Immunogenicity assessment of Ovaleap (R) (XM17) recombinant human follicle-stimulating hormone in infertile women undergoing assisted reproductive technology (ART)

被引：0
|
作者：
Zou, L. [1 ]
Mueller, A. [2 ]
Gertz, B. [2 ]
Weiss, H. [3 ]
Liu, P. [1 ]
机构：
[1] Teva Pharmaceut, Global Bioassays & Technol, W Chester, PA USA
[2] Merckle GmbH, Teva Grp, Ulm, Germany
[3] Teva Global Med Affairs, Petah Tiqwa, Israel
来源：
GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA | 2016年 / 38卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [31] Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35-40 years: A German database study (Withdrawal of Vol 89, art no 102350, 2023)
    Bielfeld, A. P.
    Schwarze, J. E.
    Verpillat, P.
    Lispi, M.
    Fischer, R.
    Hayward, B.
    Chuderland, D.
    D'Hooghe, T.
    Krussel, J. S.
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2023, 89
  • [32] Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis
    van Wely, M
    Westergaard, LG
    Bossuyt, PMM
    van der Veen, F
    [J]. FERTILITY AND STERILITY, 2003, 80 (05) : 1086 - 1093
  • [33] Seminal anti-Mullerian hormone levels during recombinant human follicle-stimulating hormone treatment in men with idiopathic infertility undergoing assisted reproduction cycles
    Caprio, F.
    De Franciscis, P.
    Trotta, C.
    Ianniello, R.
    Mele, D.
    Colacurci, N.
    [J]. ANDROLOGY, 2015, 3 (05) : 843 - 847
  • [34] Effect of age on pregnancy outcome without assisted reproductive technology in women with elevated early follicular phase serum follicle-stimulating hormone levels
    Check, JH
    Peymer, M
    Lurie, D
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 (04) : 217 - 220
  • [35] Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
    Illingworth, Peter J.
    Lahoud, Robert
    Quinn, Frank
    Chidwick, Kendal
    Wilkinson, Claire
    Sacks, Gavin
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 813 - 826
  • [36] Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
    Buehler, Klaus F.
    Fischer, Robert
    Verpillat, Patrice
    Allignol, Arthur
    Guedes, Sandra
    Boutmy, Emmanuelle
    Bilger, Wilma
    Richter, Emilia
    D'Hooghe, Thomas
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [37] Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
    Klaus F. Bühler
    Robert Fischer
    Patrice Verpillat
    Arthur Allignol
    Sandra Guedes
    Emmanuelle Boutmy
    Wilma Bilger
    Emilia Richter
    Thomas D’Hooghe
    [J]. Reproductive Biology and Endocrinology, 19
  • [38] Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation
    Koloda, Yulia
    Korsak, Vladislav
    Rozenson, Oleg
    Anshina, Margarita
    Sagamonova, Karina
    Baranov, Igor
    Yakovenko, Sergey
    D'Hooghe, Thomas
    Ershova, Anna
    Lispi, Monica
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2022, 85 : 134 - 148
  • [39] The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
    Zhao, Shen
    Xu, Huihui
    Wu, Xian
    Xia, Lan
    Li, Jian
    Zhang, Dan
    Zhang, Aijun
    Xu, Bufang
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [40] A dose finding study of recombinant human follicle-stimulating hormone (r-hFSH; follitropin alfa) in Japanese patients undergoing ovulation induction.
    Tredway, D. R.
    Taketani, Y.
    Yanaihara, T.
    Irahara, M.
    Saito, H.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S262 - S263
12345